Clinical trial hiring at venture-backed biotech is a multi-role, time-boxed exercise: study startup, site engagement, monitoring, medical monitoring, and data management typically all need to be built in the six months before first-patient-in. Recruits Lab runs multi-role clinical trial searches at the tempo the timeline demands.
A clinical trial succeeds or fails on the strength of the team running it. Site activation milestones, enrollment velocity, data quality, and safety reporting are all downstream of hire quality. The cost of a wrong clinical trial hire is rarely the recruiting fee — it is the missed enrollment milestone, the audit finding, or the readout delay.
Recruits Lab places clinical trial leadership and operations talent for venture-backed biotech, specialty pharma, and mid-cap therapeutics companies. Our practice spans CRAs, In-House CRAs, Clinical Trial Managers, Clinical Project Leads, Medical Monitors, and clinical operations leadership through VP level.
Our recruiters understand the operational distinctions that matter — single-country versus multi-region, sponsor versus CRO, oncology versus rare disease, decentralized versus traditional, and the regulatory nuance that separates a smooth pre-approval inspection from a costly one. We screen for the experience that maps to your trial.
We work both single-hire and team-build engagements. A subscription engagement scales to a Phase 2 or Phase 3 team build. A contingency engagement is the right fit for a single senior addition. Both carry a 90-day replacement guarantee.
Subscription pricing makes this work for the budgets venture-backed trials actually operate against. A flat monthly fee with unlimited active roles converts what would have been five or six contingency invoices into one operating expense.
Why this market is hard to recruit for. And how we solve each one.
Operational candidates often look strong on paper but lack real site activation velocity. We assess for it directly.
Oncology trials run differently from rare disease and CV trials. We map candidates to your TA.
Multi-region trials require ICH and EMA fluency. We screen for true global experience.
DCT operational experience is now table-stakes for many sponsors. We screen for it.
Most sponsors run trials through multiple vendors. We screen for real vendor oversight experience.
Strong trial operations talent receives constant outreach. We manage offer and resign conversations directly.
The repeatable system behind our 14-day average hire time.
We run a deep intake call with hiring managers and scientific leadership covering technical must-haves, dealbreakers, comp band, equity philosophy, and the cultural traits that predict success in your specific stage and program.
We build a fresh map of 80-150 qualified candidates from direct competitors, academic spinouts, CROs, and adjacent therapeutic areas. No database scraping — real research from a recruiter who understands the science.
Personalized outreach from a senior recruiter who can actually discuss your molecule, mechanism, or modality. Response rates run 3-5x higher than generalist agencies because the first message reads like it came from another scientist.
Five to eight vetted candidates with structured profile briefs covering technical fit, motivation, publication record where relevant, comp expectations, and risk factors. Not a resume dump — a decision document.
We manage offer construction, counter-offer scenarios, resign coaching, and start-date negotiation. Every placement carries a 90-day replacement guarantee at no additional fee.
Original observations from live searches in this specialty.
For a Phase 2 startup building an 8-15 person clinical trial function in six months, individual searches are too slow. We open all roles in parallel with a shared intake and a rolling shortlist. This is where subscription pricing pays back most concretely.
A strong Study Startup Lead can pull two months out of first-patient-in. This is the role where investing in a specialized recruiter delivers the largest single-hire payback in the clinical function. We prioritize the Study Startup search when it is one of many roles open.
Clinical trial hires who have owned CRO oversight from the sponsor side — not from the CRO side — are qualitatively different in judgment. We split the CRO-experienced pool on this axis explicitly.
2026 U.S. base salary ranges for clinical trial roles at venture-backed and mid-cap life sciences companies. Excludes equity, bonus, and sign-on. Ranges reflect Series A through commercial-stage benchmarks.
| Role | Base Salary Range |
|---|---|
| CRA II | $95K–$130K |
| Senior CRA | $125K–$165K |
| Clinical Trial Manager | $145K–$185K |
| Senior CTM | $170K–$220K |
| Clinical Project Lead | $195K–$255K |
| Director, Clinical Trials | $215K–$280K |
| VP, Clinical Trials | $310K–$420K |
Source: Recruits Lab 2026 Life Sciences Compensation dataset.
Quick answers to the questions founders and hiring leaders ask most.
Clinical trial recruiters source, screen, and qualify trial managers, CRAs, medical monitors, and clinical operations leadership for biotech and pharma trials. Recruits Lab specializes in this work and averages 14 days from kickoff to offer.
Industry average is 90 to 120 days. Recruits Lab averages 14 days through active sourcing and disciplined interview cadence.
Yes. Oncology, including solid tumor and heme, is one of our highest-volume clinical trial practice areas.
Subscription starts at $7,500 per month with unlimited active roles. Contingency is a flat 20 percent with a 90-day replacement guarantee.
Yes. Multi-hire Phase 2 and Phase 3 team builds are routine engagements.
Senior CTM with global rare disease trial experience needed ahead of a multi-region Phase 2 start.
Mapped 38 rare disease CTMs nationally. Senior recruiter ran targeted outbound, presented a five-person shortlist in 11 days.
Offer accepted in 19 days. Phase 2 activated sites on the original timeline.
"Recruits Lab understood the science from day one. They sent four interview-ready candidates inside two weeks after our internal team had spent three months on the role."
"Their subscription model let us close three scientific hires in a single quarter for less than what a single retained search would have cost us."
Yes. DCT operational experience is part of the standard candidate screen.
Yes. Trial-stage PV is a routine practice area.
Yes. Both are adjacent practice areas, often run on the same subscription.
We primarily place sponsor-side and screen for CRO-to-sponsor transitions.
Yes. Both are practice areas where TA-specific experience is critical and we screen for it.
Every placement carries a 90-day replacement guarantee. If a hire leaves or does not work out within the first 90 days, we run the search again at no additional fee.
Yes. We sign NDAs and routinely run confidential and stealth-mode searches for executive replacements, sensitive program leads, and pre-launch hires.
Book a free 30-minute hiring strategy review using the CTA on this page. We will scope the role, suggest a sourcing approach, and quote a subscription or contingency option that fits your stage.
Compensation data, hiring playbooks, case studies, and related recruiting specialties.
Four ways to engage. Pick whichever matches where you are.
30-minute strategy review with a senior recruiter. Free, no commitment.
Get startedTell us about the role. We respond with a calibration call within 24 hours.
Get startedSend a job description. We confirm fit and quote a subscription or contingency engagement.
Get startedSenior candidates: get represented to our active hiring pipeline.
Get startedRelated Resources
Hand-picked salary guides, market reports, and recruiter pages related to this topic. Authored by Darren Nelson and the Recruits Lab team.
Schedule a free 30-minute Hiring Strategy Review and walk away with a clear plan tailored to your roles.